| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/10/2005 | US20050032103 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
| 02/10/2005 | US20050032101 Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/10/2005 | US20050032097 Method for processing samples containing sperm and non-sperm cells for subsequent analysis of the sperm DNA |
| 02/10/2005 | US20050032090 Detection of Giardia |
| 02/10/2005 | US20050032088 Nucleotide sequences coding 2,5-diketo-D-gluconic acid permease for use in enhancing ascorbic acid transport across membrane; food processing and preparation; nutraceuticals |
| 02/10/2005 | US20050032086 Providing cell-free system for use in vitro translation and/or transcription |
| 02/10/2005 | US20050032085 Novel chromophores/fluorophores and methods for using the same |
| 02/10/2005 | US20050032080 Method for quantifying a target nucleic acid |
| 02/10/2005 | US20050032078 Methods for the detection, analysis and isolation of nascent proteins |
| 02/10/2005 | US20050032076 Polymerase chain reactions; exonucleases; microfluidics |
| 02/10/2005 | US20050032068 Oligomers hybridize with each other, one of which includes peptide nucleic acid or mimic, a morpholino nucleic acid, hexose sugar with amide linkage, cyclohexenyl nucleic acid or an acyclic backbone modification; gene expression inhibition |
| 02/10/2005 | US20050032067 Nucleosides; RNA-induced silencing complex; RNA interference; gene expression inhibition |
| 02/10/2005 | US20050032064 Method and device for identifying substances capable of modulating adipocyte differentiation |
| 02/10/2005 | US20050032061 Method of storing and/or delivering an oligomer and/or polymer applied on a support, and supports thereof |
| 02/10/2005 | US20050032059 Genetically modified hydrolase comprising enhanced activity for use in hydrolysis of starch to glucose; textile treatment; preparation of animal feeds |
| 02/10/2005 | US20050032058 Using aberrant homeobox gene expression in hematopoietic cells as diagnostic indicator of cell proliferfative disorders |
| 02/10/2005 | US20050032057 Methods for preparing nucleic acid samples |
| 02/10/2005 | US20050032054 Screening for novel bioactivities |
| 02/10/2005 | US20050032050 Using sequence data to generate oligonucleotides sharing sequence homology to stress resistance genes and which can be used to screen and isolate clones comprising complimentary sequences in plant genomic libraries |
| 02/10/2005 | US20050032049 Electrochemical method for detecting nucleic acids |
| 02/10/2005 | US20050032047 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay |
| 02/10/2005 | US20050032045 Viral fusion protein comprising a portion of gut associated lymphoid tissue (GALT) cell surface binding protein for use in targeted protein delivery and immunotherapeutics; vaccines |
| 02/10/2005 | US20050032044 Lipid and cryoprotectant; gene therapy |
| 02/10/2005 | US20050032043 Recombinant negative strand RNA virus expression systems and vaccines |
| 02/10/2005 | US20050032041 Using viral protein as diagnostic indicator of infection in grapes; immunodiagnostics |
| 02/10/2005 | US20050032039 HIV-specific T-cell induction |
| 02/10/2005 | US20050031646 Immunogens; polysaccharide conjugate antigens derived from pathogenic bacterium conjugated to protein D from Haemophilus influenzae |
| 02/10/2005 | US20050031644 Modifying wild strain of enteroinvasive Shigella; cannot spread within infected cells and from infected to uninfected cells of the host; vaccines; deactivation by inserting transposon into gene; mutagenizing; genetically engineered by allelic exchange |
| 02/10/2005 | US20050031643 Microorganisms for therapy |
| 02/10/2005 | US20050031642 Clonal lentogenic oncolytic strain of Newcastle Disease Virus and hemaglutinin-neuraminidase (HN) gene |
| 02/10/2005 | US20050031641 Recombinant vaccine against West Nile Virus |
| 02/10/2005 | US20050031636 Papilloma virus capsomere vaccine formulations and methods of use |
| 02/10/2005 | US20050031631 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them |
| 02/10/2005 | US20050031629 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies |
| 02/10/2005 | US20050031628 Chimeric antigens for breaking host tolerance to foreign antigens |
| 02/10/2005 | US20050031624 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 02/10/2005 | US20050031623 Blot analysis of urine/serum; proteoglycan-like domains; oncogenes; hybridomas |
| 02/10/2005 | US20050031618 Induction of tolerance by apoptotic and/or necrotic cells |
| 02/10/2005 | US20050031617 Antibodies specific for cancer associated antigen SM5-1 and uses thereof |
| 02/10/2005 | US20050031604 Secreted by serpent venom glands; endogenous vasopeptidase inhibitors; angiotensin converting enzyme inhibitors; vasodilating and anti-hypertensive action; bradykinins; mass spectrometry |
| 02/10/2005 | US20050031593 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 02/10/2005 | US20050031591 Tumor-specific promotor and use thereof |
| 02/10/2005 | US20050031590 Adenoviral vectors having a protein IX deletion |
| 02/10/2005 | US20050031583 Uses of opg to modulate immune responses |
| 02/10/2005 | US20050031579 Polymer encapsulation of adenoviruses |
| 02/10/2005 | US20050029246 Zone heating of specimen carriers |
| 02/10/2005 | US20050029191 Separation medium, its preparation and its use |
| 02/10/2005 | US20050029104 Process for preparing processed sample liquid solution for electrophoresis |
| 02/10/2005 | US20050028906 Annealing surface treatment; crystal growth enhancer |
| 02/10/2005 | DE10332597A1 Endowing plant/plant cells with trait of interest by expressing RNA sequence of interest, by providing plant cells with first and second vectors containing sequence encoding target RNA and selecting cells endowed with trait of interest |
| 02/10/2005 | CA2820028A1 Multimeric oxidoreductases |
| 02/10/2005 | CA2758178A1 Human skin equivalents expressing exogenous polypeptides |
| 02/10/2005 | CA2537268A1 Partially double stranded nucleic acid molecule |
| 02/10/2005 | CA2536120A1 Polymer encapsulation of adenoviruses |
| 02/10/2005 | CA2534991A1 Short interfering rna as an antiviral agent for hepatitis c |
| 02/10/2005 | CA2534382A1 Lafora's disease gene |
| 02/10/2005 | CA2534360A1 Methods for expression and purification of immunotoxins |
| 02/10/2005 | CA2534353A1 Adipocyte complement related protein zacrp11 |
| 02/10/2005 | CA2534351A1 Accelerated vaccination |
| 02/10/2005 | CA2534309A1 Method of evaluating compound efficacious in treating obesity by using slc25a10 |
| 02/10/2005 | CA2534299A1 System for producing dimeric proteins based on the escherichia coli hemolysin transport system |
| 02/10/2005 | CA2534275A1 Pichia methanolica secretory signal |
| 02/10/2005 | CA2534077A1 Antibodies and methods for generating genetically altered antibodies with enhanced effector function |
| 02/10/2005 | CA2534055A1 Antibody cdr polypeptide sequences with restricted diversity |
| 02/10/2005 | CA2533941A1 Novel nucleic acids from sesame plants |
| 02/10/2005 | CA2533938A1 Multimeric oxidoreductases |
| 02/10/2005 | CA2533936A1 Metabolically engineered bacterial strains having enhanced 2-keto-d-gluconate accumulation |
| 02/10/2005 | CA2533789A1 Epha2 t-cell epitope agonists and uses therefor |
| 02/10/2005 | CA2533687A1 A method of producing an anticoagulation effect |
| 02/10/2005 | CA2533613A1 Method for the production of multiply-unsaturated fatty acids in transgenic organisms |
| 02/10/2005 | CA2533593A1 Altered antibodies having improved antigen-binding affinity |
| 02/10/2005 | CA2533512A1 Antagonists and agonists of ldcam and methods of use |
| 02/10/2005 | CA2533423A1 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer |
| 02/10/2005 | CA2533297A1 Anti-vegf antibodies |
| 02/10/2005 | CA2533160A1 Genotoxicity testing |
| 02/10/2005 | CA2531684A1 Binding molecules against sars-coronavirus and uses thereof |
| 02/10/2005 | CA2531320A1 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration |
| 02/10/2005 | CA2531231A1 Uranium-chelating peptides and uses thereof |
| 02/10/2005 | CA2530172A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/10/2005 | CA2521284A1 Novel glyphosate-n-acetyltransferase (gat) genes |
| 02/09/2005 | EP1505517A1 Mutant sequence analyzer |
| 02/09/2005 | EP1505161A2 Detection of polymorphisms in Epstein-Barr virus (EBV) DNA for the prediction and detection of EBV-associated cancers |
| 02/09/2005 | EP1505160A2 5'nucleases derived from thermostable DNA polymerase |
| 02/09/2005 | EP1505157A1 Screening assay for anti-bacterial compounds |
| 02/09/2005 | EP1505155A1 Novel carbonyl reductase, gene thereof and use of the same |
| 02/09/2005 | EP1505154A1 Vector with modified protease-dependent tropism |
| 02/09/2005 | EP1505153A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 02/09/2005 | EP1505152A1 EXPRESSION SYSTEMS FOR STEM LOOP RNA MOLECULE HAVING RNAi EFFECT |
| 02/09/2005 | EP1505151A2 Directed evolution method |
| 02/09/2005 | EP1505089A1 Cationic (alkyl)acrylamide derivative, polymer based on these derivates, and transfection system comprising said polymer |
| 02/09/2005 | EP1505075A1 Antibody to human insulin-like growth factor |
| 02/09/2005 | EP1505074A1 Histamine receptor h3 ordinary activity mutant and utilization thereof |
| 02/09/2005 | EP1504766A1 Drug- or gene-carrier composition having lowered hemagglutinin activity |
| 02/09/2005 | EP1504764A1 Treatment of liver fibrosis with antagonists of alpha V beta 6 integrin |
| 02/09/2005 | EP1504258A2 Multi-functional microarrays and methods |
| 02/09/2005 | EP1504127A1 Amplification-hybridisation method for detecting and typing human papillomavirus |
| 02/09/2005 | EP1504124A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions |
| 02/09/2005 | EP1504123A2 Methods for discovering tumor biomarkers and diagnosing tumors |
| 02/09/2005 | EP1504120A2 Methods for evaluating a disease condition by detection of particle and non-particle bound nucleic acids in blood plasma and serum |
| 02/09/2005 | EP1504119A4 Method for ligating nucleic acids and molecular cloning |